生命科学仪器2024，Vol.22Issue(4)：96-98,3.DOI:10.11967/2024220833
PDCA循环在规范临床应用质子泵抑制剂管理中的实践
Practice of PDCA cycle in standardizing the management of proton pump inhibitors in clinical practice
摘要
Abstract
Objective:To explore the practice of PDCA cycle in regulating the clinical application of proton pump in-hibitors.Methods:1200 medical orders and prescriptions were randomly selected from December 2020 to March 2021(pre-intervention group),and from April 2021 to July 2021(intervention group 1),and from August 2021 to November 2021(intervention group 2)after PDCA cycle intervention.From December 2021 to March 2022(in-tervention group 3)and from April 2022 to July 2022(intervention group 4),there were 1200 orders and prescrip-tions for proton pump inhibitors.The rational drug use of each group was compared and analyzed.Results:After the PDCA cycle management,the rational rate of proton pump inhibitor application in intervention group 1,inter-vention group 2,intervention group 3 and intervention group 4 was higher than that before the intervention group(P<0.05).The irrational rate of proton pump inhibitor application in intervention group 1,intervention group 2,intervention group 3 and intervention group 4 after PDCA cycle management was lower than that in pre-interven-tion group(P<0.05).Conclusion:Active PDCA cycle management intervention in regulating clinical drug man-agement can achieve better management effects,further improve the level of hospital pharmaceutical care and man-agement quality,and ensure the rational use of clinical proton pump inhibitors.关键词
质子泵抑制剂/PDCA循环/用药管理/合理用药Key words
proton pump inhibitor/PDCA cycle/Drug management/Rational drug use分类
医药卫生引用本文复制引用
冼志娥,黄绍雄,周哲瑜,陶珊花..PDCA循环在规范临床应用质子泵抑制剂管理中的实践[J].生命科学仪器,2024,22(4):96-98,3.基金项目
肇庆市科技计划项目合同书(2021040314034) （2021040314034）
